Measuring handgrip strength is one of the main ways of detecting sarcopenia, a syndrome characterized by loss of muscle mass, force and function.
Sarcopenia, a clinical syndrome characterized by progressive and extensive decline in skeletal muscle mass, force and function, is widely considered part of aging. Early diagnosis is extremely important and begins with handgrip measurement using a dynamometer.
A recent study by researchers at the Federal University of São Carlos (UFSCar) in São Paulo state, Brazil, collaborating with colleagues at University College London (UCL) in the United Kingdom, concluded that the diagnosis protocol should be changed by raising the handgrip strength cutoff point used to detect muscle weakness. They say new criteria proposed in their paper would be better predictors of mortality risk in older adults, enabling healthcare professionals to detect the onset of sarcopenia earlier and more accurately.
A new large scale genetic analysis has found biological mechanisms that contribute to making people more susceptible to muscle weakness in later life, finding that diseases such as osteoarthritis and diabetes may play a large role in susceptibility.
As we get older we lose muscle strength, and in some people this severe weakness impacts their ability to live everyday lives, a condition called sarcopenia. Around 10 per cent of people over 50 experience sarcopenia. Many causes thought to impact likelihood of developing this weakness, which is linked to higher death rates.
In a genetic analysis of over 250,000 people aged over 60 from UK Biobank and 21 other cohorts, an international team led by researchers at the University of Exeter looked at hand grip strength, using thresholds of loss of muscle function derived from international definitions of sarcopenia.
The team, including collaborators from the USA and the Netherlands, then conducted a genetic analysis, and found specific biological mechanisms push some people towards sarcopenia, while protecting others. The study, published in Nature Communications identified 15 areas of the genome, or loci, associated with muscle weakness, including 12 loci not implicated in previous analyses of continuous measures of grip strength.
Biomarkers in the blood including red blood cells and inflammation may also share causal pathways with sarcopenia. Together, these results highlight specific areas for intervention or for identifying those at most risk.
Lead author Garan Jones said: “The strongest associations we found were close to regions of the genome regulating the immune system, and growth and development of the muscloskeletal system. However, we also discovered associations with regions not previously known to be linked to muscloskeletal traits.
“We found that our analysis of muscle weakness in older people shared common genetic pathways with metabolic diseases such as type-2 diabetes, and auto-immune conditions such as osteoarthritis and rheumatoid arthritis. In subgroups of people with increased risk of these conditions, sarcopenia may be a key outcome to look out for and prevent.
“We hope that by understanding the genetic contributions to muscle weakness with age, we will be able to highlight possible therapeutic interventions earlier in life, which would lead to a happier and healthier old age.”
I ran across this excellent discussion of senior cycling on RoadBikeRider.com. They have graciously permitted me to reprint it. See permission at end.
RBR Editor’s Note: Coach John Hughes copied me on a recent email exchange he had with Marty Hoganson, an RBR reader with whom he had ridden on tours in years gone by. Marty wondered what, if any, differences there are in terms of recovery, motivation, etc., between 50-somethings and 70-somethings. Both agreed to let me share the exchange with RBR readers. It provides a wealth of solid, useful information.
Marty Asked:
These days I live and ride in Yuma, Arizona. I am involved in our local bike club called Foothills Bicycle Club, which is primarily made up of retired folks – late-50s to mid-80s. Many strong riders in their 60s and 70s, for their ages — or any age, for that matter.
Now that I am older also I have taken some interest in your articles on cycling and aging. I was wondering how cycling over 70 relates to your articles on cycling over 50? I’m pretty sure they don’t necessarily relate well. I am arriving in that 70+ age group this year, and have been feeling the difference in recovery time and healing from injuries for quite a few years.
The plus 70 year old blogger riding with his dog on Northerly Island in Chicago.
What used to take three days to recover from, while riding a tour, may now take longer than the tour lasts. Maybe months longer. I ride year-round and still ride pretty strong, but I’m also experiencing a loss of interest in doing long days. I still like to do long tours, but with shorter days. I’m wondering if the lack of desire or drive might be a major contributing factor in the loss of performance, or if the loss of performance leads to the lack of desire to train harder? Also, if the shorter days might lead to the longer recovery times? Continue reading →